SEOUL,South Korea,Dec. 13,2024--Korea Zinc(KRX:010130) has successfully completed the \'Onsen Smelter Rationalization Project,\' a key initiative undertaken throughout 2024 to strengthen the competit
Today is the launching of the short film \'The dream that beat a volcano\',showing Vicente Leal,a resident of the Canary Islands who has been fighting since 2021 to fulfill a dream that the volcano t
BEIJING,Dec. 16,2024-- JA Solar\'s Bycium+ cell has achieved a significant breakthrough,having reached a new high in cell efficiency and set a new record with an open-circuit voltage of 748.6mV—the h
Marks another major milestone in the redevelopment of the premiumsteelmaking coal mine
ST. LOUIS,Dec. 17,2024--Peabody (NYSE: BTU) today announced that it has successfully shipped the first product f
If your implant/replacement involved Exactech products – including Optetrak,Optetrak Logic,Truliant,Vantage,Connexion GXL,and Equinoxe – your attention to this notice is important.
Experience Washoku as a Sacred Connection Between Humanity,Nature and Tradition
OSAKA,Japan,Dec. 17,2024--As Osaka prepares to host the highly anticipated Expo 2025,the city welcomes an extraordinary
BEIJING,Dec. 17,2024-- The Badminton World Federation (BWF) has encountered issues this year over how to best maintain players\' health and well-being on the court. Thomas Lund,BWF secretary-general,e
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).